Pre-treatment circulating leptin/ghrelin ratio as a non-invasive marker to identify patients likely to regain the lost weight after an energy restriction treatment

Journal of Endocrinological Investigation

Volumn 37, Issue 2, 2014, Pages 119-126

  Crujeiras, A B ^a,b   Diaz Lagares A ^c   Abete, I ^b,d   Goyenechea, E ^b,d   Amil, M ^a,b   Martinez J A ^b,d   Casanueva, F F ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c Instituto de Investigación Sanitaria de Santiago de Compostela IDIS   (Spain)

^d UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Diagnostic biomarkers; Hypocaloric diet; Obesity; Weight maintenance; Weight regain

Indexed keywords

GHRELIN; LEPTIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIET RESTRICTION; DIET THERAPY; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HUMAN; INTERVENTION STUDY; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; BIOLOGICAL MARKERS; CALORIC RESTRICTION; DIET, REDUCING; FEMALE; GHRELIN; HUMANS; LEPTIN; MALE; OBESITY; OVERWEIGHT; PROGNOSIS; TREATMENT FAILURE; WEIGHT GAIN;

EID: 84896493540     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-013-0004-2     Document Type: Article

References (39)

1. Maclean PS, Bergouignan A, Cornier MA, Jackman MR (2011) Biology's response to dieting: the impetus for weight regain. Am J Physiol Regul Integr Comp Physiol 301:R581-R600
2. ter Bogt NC, Bemelmans WJ, Beltman FW, Broer J, Smit AJ, van der Meer K (2011) Preventing weight gain by lifestyle intervention in a general practice setting: three-year results of a randomized controlled trial. Arch Intern Med 171:306-313
3. Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307:491-497
4. Gutierrez-Fisac JL, Guallar-Castillon P, Leon-Munoz LM, Graciani A, Banegas JR, Rodriguez-Artalejo F (2012) Prevalence of general and abdominal obesity in the adult population of Spain, 2008-2010: the ENRICA study. Obes Rev 13:388-392
5. Abete I, Parra MD, Zulet MA, Martinez JA (2006) Different dietary strategies for weight loss in obesity: role of energy and macronutrient content. Nutr Res Rev 19:5-17
6. Fernandez JM, Rosado-Alvarez D, Da Silva-Grigoletto ME et al (2012) Moderate-to-high intensity training and hypocaloric Mediterranean diet enhance endothelial progenitor cells and fitness in subjects with metabolic syndrome. Clin Sci (Lond) 123:361-373
7. Astrup A, Rossner S, Van Gaal L et al (2009) Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 374:1606-1616
8. Sumithran P, Prendergast LA, Delbridge E et al (2011) Longterm persistence of hormonal adaptations to weight loss. N Engl J Med 365:1597-1604
9. Schur EA, Cummings DE, Callahan HS, Foster-Schubert KE (2008) Association of cognitive restraint with ghrelin, leptin, and insulin levels in subjects who are not weight-reduced. Physiol Behav 93:706-712
10. Levin BE (2004) The drive to regain is mainly in the brain. Am J Physiol Regul Integr Comp Physiol 287:R1297-R1300
11. Seoane LM, Al-Massadi O, Caminos JE, Tovar SA, Dieguez C, Casanueva FF (2007) Sensory stimuli directly acting at the central nervous system regulate gastric ghrelin secretion. An ex vivo organ culture study. Endocrinology 148:3998-4006
12. Cummings DE (2006) Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav 89:71-84
13. Enomoto M, Nagaya N, Uematsu M et al (2003) Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans. Clin Sci (Lond) 105:431-435
14. Crujeiras AB, Casanueva FF (2012) Decreased ghrelin levels: the cause of obesity and weight regain? Expert Rev Endocrinol Metab 7:127-129
15. Davis JF, Choi DL, Benoit SC (2010) Insulin, leptin and reward. Trends Endocrinol Metab 21:68-74
16. Gil-Campos M, Aguilera CM, Canete R, Gil A (2006) Ghrelin: a hormone regulating food intake and energy homeostasis. Br J Nutr 96:201-226
17. Goyenechea E, Parra D, Crujeiras AB, Abete I, Martinez JA (2009) A nutrigenomic inflammation-related PBMC-based approach to predict the weight-loss regain in obese subjects. Ann Nutr Metab 54:43-51
18. Mutch DM, Pers TH, Temanni MR et al (2011) A distinct adipose tissue gene expression response to caloric restriction predicts 6-mo weight maintenance in obese subjects. Am J Clin Nutr 94:1399-1409
19. Wang P, Holst C, Andersen MR et al (2011) Blood profile of proteins and steroid hormones predicts weight change after weight loss with interactions of dietary protein level and glycemic index. PLoS ONE 6:e16773
20. Goyenechea E, Crujeiras AB, Abete I, Martinez JA (2009) Expression of two inflammation-related genes (RIPK3 and RNF216) in mononuclear cells is associated with weight-loss regain in obese subjects. J Nutrigenet Nutrigenomics 2:78-84
21. Crujeiras AB, Goyenechea E, Abete I et al (2010) Weight regain after a diet-induced loss is predicted by higher baseline leptin and lower ghrelin plasma levels. J Clin Endocrinol Metab 95:5037-5044
22. Strohacker K, McCaffery JM, Maclean PS, Wing RR (2013) Adaptations of leptin, ghrelin or insulin during weight loss as predictors of weight regain: a review of current literature. Int J Obes (Lond). doi:10.1038/ijo.2013.118
23. Crujeiras AB, Parra D, Goyenechea E, Abete I, Martinez JA (2009) Tachyphylaxis effects on postprandial oxidative stress and mitochondrial-related gene expression in overweight subjects after a period of energy restriction. Eur J Nutr 48:341-347
24. Mera R, Thompson H, Prasad C (1998) How to calculate sample size for an experiment: a case-based description. Nutr Neurosci 1:87-91
25. Obuchowski NA, Lieber ML, Wians FH Jr (2004) ROC curves in clinical chemistry: uses, misuses, and possible solutions. Clin Chem 50:1118-1125
26. Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839-843
27. Elmi A, Hedgire SS, Covarrubias D, Abtahi SM, Hahn PF, Harisinghani M (2013) Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer. Clin Radiol 68:e524-e531
28. Bruns DE, Huth EJ, Magid E, Young DS (2000) Toward a checklist for reporting of studies of diagnostic accuracy of medical tests. Clin Chem 46:893-895
29. Hlatky MA, Greenland P, Arnett DK et al (2009) Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 119:2408-2416
30. Diaz-Lagares A, Alegre E, Arroyo A et al (2011) Evaluation of multiple serum markers in advanced melanoma. Tumour Biol 32:1155-1161
31. Popovic V, Leal A, Micic D et al (2000) GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet 356:1137-1142
32. Sturgeon CM, Duffy MJ, Hofmann BR et al (2010) National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem 56:e1-e48
33. MacLean PS, Higgins JA, Jackman MR et al (2006) Peripheral metabolic responses to prolonged weight reduction that promote rapid, efficient regain in obesity-prone rats. Am J Physiol Regul Integr Comp Physiol 290:R1577-R1588
34. Campion J, Milagro FI, Goyenechea E, Martinez JA (2009) TNFalpha promoter methylation as a predictive biomarker for weightloss response. Obesity (Silver Spring) 17:1293-1297
35. Crujeiras AB, Campion J, Diaz-Lagares A et al (2013) Association of weight regain with specific methylation levels in the NPY and POMC promoters in leukocytes of obese men: a translational study. Regul Pept 186C:1-6
36. Altman DG, Bland JM (1994) Diagnostic tests. 1: Sensitivity and specificity. BMJ 308:1552
37. Larsen TM, Dalskov SM, van Baak M et al (2010) Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med 363:2102-2113
38. Sandholt CH, Sparso T, Grarup N et al (2010) Combined analyses of 20 common obesity susceptibility variants. Diabetes 59:1667-1673
39. Sierra-Johnson J, Romero-Corral A, Somers VK et al (2009) IGFI/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome. Clin Sci (Lond) 116:507-512